This eCME is directed to primary care clinicians (family physicians, nurse practitioners and pharmacists) in the therapeutic area of pharmacogenetic testing and personalized medicine. This one-hour program will be accredited through the CFPC and CCCEP.
Pharmacogenomics (PGx) focuses on understanding how genes affect individual responses to medications, i.e., the relationship between drug responses and genetic variants. PGx testing provides objective data about specific aspects of an individual’s genetic makeup that may predict an individual’s response to medications. For example, the liver enzyme CYP2D6 is involved in metabolizing a quarter of all prescriptions and exists in more than 160 known variants. Some variants can negatively impact how particular drugs are metabolized by individuals who carry the variants.